Cargando…
Topical Endoxifen for Mammographic Density Reduction—A Randomized Controlled Trial
Although breast cancer incidence is increasing, there are few primary preventive initiatives. Tamoxifen can reduce breast cancer incidence but is rarely used for primary prevention due to adverse events and tolerance issues. We tested if endoxifen, a tamoxifen metabolite, applied directly to the ski...
Autores principales: | Bäcklund, Magnus, Eriksson, Mikael, Gabrielson, Marike, Hammarström, Mattias, Quay, Steve, Bergqvist, Jenny, Hellgren, Roxanna, Czene, Kamila, Hall, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256025/ https://www.ncbi.nlm.nih.gov/pubmed/35604960 http://dx.doi.org/10.1093/oncolo/oyac102 |
Ejemplares similares
-
Time to Mammographic Density Decrease After Exposure to Tamoxifen
por: Bäcklund, Magnus, et al.
Publicado: (2022) -
Predictors of mammographic microcalcifications
por: Azam, Shadi, et al.
Publicado: (2020) -
Mammographic microcalcifications and risk of breast cancer
por: Azam, Shadi, et al.
Publicado: (2021) -
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial
por: Eriksson, Mikael, et al.
Publicado: (2021) -
Hormonal determinants of mammographic density and density change
por: Gabrielson, Marike, et al.
Publicado: (2020)